This analysis revealed increased expression of regulatory Breg markers, including Havcr1, Il10, Il12a, and Ebi3, in HCA-1 HCC samples from STING agonist-treated mice (Fig. 5A). The gene discussed is IL10; the disease is hepatocellular carcinoma.